Immunopathogenesis of Atopic Dermatitis: Focus on Interleukins as Disease Drivers and Therapeutic Targets for Novel Treatments.

Makowska, Karolina; Nowaczyk, Joanna; Blicharz, Leszek; Waskiel-Burnat, Anna; Czuwara, Joanna; Olszewska, Malgorzata; Rudnicka, Lidia

Makowska, Karolina; Nowaczyk, Joanna; Blicharz, Leszek; Waskiel-Burnat, Anna; Czuwara, Joanna; Olszewska, Malgorzata; Rudnicka, Lidia.

Afiliación

Makowska K; Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.
Nowaczyk J; Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.
Blicharz L; Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.
Waskiel-Burnat A; Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.
Czuwara J; Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.
Olszewska M; Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.
Rudnicka L; Department of Dermatology, Medical University of Warsaw, 02-008 Warsaw, Poland.

Int J Mol Sci ; 24(1)2023 Jan 02.

Article en En | MEDLINE | ID: mdl-36614224

Asunto(s)

Dermatitis Atópica; Enfermedades de la Piel; Humanos; Dermatitis Atópica/patología; Interleucinas/metabolismo; Prurito/tratamiento farmacológico; Piel/metabolismo; Enfermedades de la Piel/complicaciones

Palabras clave

JAK inhibitors; atopic dermatitis; biological treatment; biologics; cytokines; endotypes; interleukins; pathogenesis; phenotypes; small molecules

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Enfermedades de la Piel / Dermatitis Atópica Límite: Humans Idioma: En Revista: Int J Mol Sci Año: 2023 Tipo del documento: Article País de afiliación: Polonia

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google